192461-96-4

Usage

Uses

Used in Pharmaceutical Industry:
(5Z,11Z,14Z)-8,9-dihydroxyicosa-5,11,14-trienoic acid is used as a potential therapeutic agent for addressing metabolic disorders and chronic inflammation. Its association with abnormal lipoprotein oxylipins suggests that it may play a role in modulating inflammatory responses and improving metabolic health.
Used in Research Applications:
In the field of medical and biological research, (5Z,11Z,14Z)-8,9-dihydroxyicosa-5,11,14-trienoic acid serves as an important biochemical marker for studying the pathophysiology of metabolic disorders and chronic inflammation. It can be used to investigate the underlying mechanisms and potential therapeutic targets for these conditions.
Used in Diagnostic Applications:
(5Z,11Z,14Z)-8,9-dihydroxyicosa-5,11,14-trienoic acid can be utilized as a diagnostic biomarker to identify individuals at risk for metabolic disorders and chronic inflammation. Its measurement in biological samples may help in the early detection and monitoring of these conditions.

InChI:InChI=1/C20H34O4/c1-2-3-4-5-6-7-8-9-12-15-18(21)19(22)16-13-10-11-14-17-20(23)24/h6-7,9-10,12-13,18-19,21-22H,2-5,8,11,14-17H2,1H3,(H,23,24)/b7-6-,12-9-,13-10-

Upstream product

• 184488-44-6 8,9-epoxyeicosa-5(Z),11(Z),14(Z)-trienoic acid 

Relevant academic research and scientific papers

Maternal glyphosate exposure causes autism-like behaviors in offspring through increased expression of soluble epoxide hydrolase

Epidemiological studies suggest that exposure to herbicides during pregnancy might increase risk for autism spectrum disorder (ASD) in offspring. However, the precise mechanisms underlying the risk of ASD by herbicides such as glyphosate remain unclear. Soluble epoxide hydrolase (sEH) in the metabolism of polyunsaturated fatty acids is shown to play a key role in the development of ASD in offspring after maternal immune activation. Here, we found ASD-like behavioral abnormalities in juvenile offspring after maternal exposure to high levels of formulated glyphosate. Furthermore, we found higher levels of sEH in the prefrontal cortex (PFC), hippocampus, and striatum of juvenile offspring, and oxylipin analysis showed decreased levels of epoxy-fatty acids such as 8 (9)-EpETrE in the blood, PFC, hippocampus, and striatum of juvenile offspring after maternal glyphosate exposure, supporting increased activity of sEH in the offspring. Moreover, we found abnormal composition of gut microbiota and short-chain fatty acids in fecal samples of juvenile offspring after maternal glyphosate exposure. Interestingly, oral administration of TPPU (an sEH inhibitor) to pregnant mothers from E5 to P21 prevented ASD-like behaviors such as social interaction deficits and increased grooming time in the juvenile offspring after maternal glyphosate exposure. These findings suggest that maternal exposure to high levels of glyphosate causes ASD-like behavioral abnormalities and abnormal composition of gut microbiota in juvenile offspring, and that increased activity of sEH might play a role in ASD-like behaviors in offspring after maternal glyphosate exposure. Therefore, sEH may represent a target for ASD in offspring after maternal stress from occupational exposure to contaminants.